Korea's Hospital Polypharmacy Program Cuts 90-Day Readmissions in Elders
For pharmacists managing complex, high-risk medication regimens in hospitalized older adults, this national program shows that multidisciplinary inpatient medication reconciliation and deprescribing reduce readmissions and return nearly fourfold on payer investment.
📅 Journal publication: Sep 2026(online Aug 8, 2026)·Last updated: Aug 12, 2026
Polypharmacy management slashes readmission rates and costs for older adults.
Polypharmacy is linked to negative outcomes in older adults, and managing it can reduce readmission rates and healthcare costs. The polypharmacy management program lowered 90-day readmission risk (adjusted hazard ratio 0.85) and reduced hospitalization costs (USD$6400 vs USD$6740, P = 0.005). Despite the lack of randomization, propensity score matching strengthens the findings, suggesting potential for broader implementation in healthcare systems. Korea's polypharmacy management program significantly reduced readmissions and healthcare costs for older adults.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Jang S, Lim J, Moon A, Lee JY, Ah YM, Lee HJ, Lee SY, Kim JH, Jang S
Citation:Jang S, Lim J, Moon A, et al. Clinical and Economic Outcomes of Korea's National Polypharmacy Management Program for Hospitalized Older Adults: 90-Day Readmission and Healthcare Costs. Drugs & aging. 2026;43(9):849-860. doi:10.1007/s40266-026-01325-6